ITZIAR
VERGARA MICHELTORENA
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Sanitaria Biocruces Bizkaia (3)
2022
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340
-
Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
eClinicalMedicine, Vol. 51
2020
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2